Sign in

Cytek Biosciences, Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Total revenue 0.20 0.20 0.19 0.16 0.13 0.09 0.06
Cost of revenue 0.10 0.09 0.08 0.06 0.05 0.04 0.03
Gross profit 0.10 0.11 0.11 0.10 0.08 0.05 0.03
Total operating expenses + 0.14 0.13 0.14 0.10 0.07 0.04 0.05
Operating income -0.04 -0.02 -0.03 0.00 0.01 0.01 -0.02
Non-operating income (net) 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Income before tax -0.03 -0.01 -0.02 0.00 0.01 0.01 -0.02
Income tax expense 0.04 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.07 -0.01 -0.01 0.00 0.00 0.02 -0.02
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total revenue 0.04 0.06 0.05 0.05 0.04 0.06 0.05 0.05 0.04 0.06 0.05 0.05 0.04 0.05 0.04 0.04 0.04 0.04 0.03 0.03 0.02 0.03 0.03 0.02 0.02
Cost of revenue 0.02 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.02 0.01 0.02 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Gross profit 0.02 0.03 0.03 0.02 0.02 0.03 0.03 0.03 0.02 0.03 0.03 0.03 0.02 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.01 0.01
Total operating expenses + 0.04 0.04 0.04 0.03 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01
Operating income -0.02 -0.01 -0.01 -0.01 -0.01 0.00 0.00 -0.01 -0.01 0.00 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.02 0.00 -0.01 -0.01 -0.01 0.01 0.00 -0.01 -0.01 0.00 0.00 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00
Income tax expense 0.00 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00
Net income -0.02 -0.04 -0.01 -0.01 -0.01 0.01 0.00 -0.01 -0.01 0.01 -0.01 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Total cash and short-term investments + 0.26 0.28 0.26 0.34 0.36 0.17 0.03
Accounts receivable, net 0.07 0.06 0.06 0.05 0.03 0.02 0.02
Inventories 0.05 0.04 0.06 0.05 0.03 0.02 0.02
Other current assets 0.01 0.01 0.01 0.01 0.01 0.00 0.00
Total current assets 0.39 0.40 0.39 0.45 0.43 0.21 0.07
Total non-current assets + 0.07 0.10 0.10 0.07 0.03 0.01 0.00
Total assets 0.46 0.50 0.49 0.52 0.46 0.22 0.07
Total current liabilities + 0.08 0.07 0.06 0.05 0.03 0.03 0.02
Total non-current liabilities + 0.04 0.04 0.05 0.04 0.02 0.21 0.09
Total liabilities 0.12 0.10 0.10 0.09 0.06 0.24 0.11
Total stockholders' equity + 0.34 0.40 0.39 0.43 0.41 -0.02 -0.04
Common shares outstanding 128 131 135 139 134 133 133
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total cash and short-term investments + 0.26 0.26 0.26 0.26 0.27 0.28 0.28 0.28 0.27 0.26 0.29 0.30 0.30 0.34 0.34 0.35 0.36 0.36 0.38 0.16 0.17 0.17 0.00 0.00 0.03
Accounts receivable, net 0.06 0.07 0.06 0.06 0.06 0.06 0.05 0.04 0.05 0.06 0.06 0.05 0.05 0.05 0.04 0.04 0.03 0.03 0.03 0.03 0.02 0.02
Inventories 0.05 0.05 0.05 0.05 0.05 0.04 0.05 0.05 0.05 0.06 0.07 0.07 0.07 0.05 0.05 0.05 0.04 0.03 0.03 0.03 0.03 0.02
Other current assets 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Total current assets 0.38 0.39 0.39 0.38 0.38 0.40 0.39 0.38 0.39 0.39 0.42 0.42 0.43 0.45 0.44 0.44 0.44 0.43 0.44 0.22 0.21 0.21 0.03
Total non-current assets + 0.07 0.07 0.11 0.11 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.07 0.06 0.05 0.05 0.03 0.01 0.01 0.01 0.01 -0.03
Total assets 0.45 0.46 0.49 0.49 0.48 0.50 0.49 0.48 0.49 0.49 0.52 0.53 0.52 0.52 0.50 0.49 0.49 0.46 0.45 0.23 0.22 0.22
Total current liabilities + 0.08 0.08 0.08 0.07 0.07 0.07 0.06 0.05 0.06 0.06 0.06 0.05 0.06 0.05 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.03
Total non-current liabilities + 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.05 0.05 0.05 0.04 0.04 0.04 0.04 0.04 0.02 0.02 0.21 0.21 0.21
Total liabilities 0.12 0.12 0.12 0.12 0.10 0.10 0.11 0.09 0.10 0.10 0.10 0.10 0.10 0.09 0.08 0.08 0.08 0.06 0.05 0.24 0.24 0.24
Total stockholders' equity + 0.33 0.34 0.38 0.38 0.38 0.40 0.39 0.39 0.39 0.39 0.42 0.42 0.42 0.43 0.42 0.41 0.41 0.41 0.40 -0.01 -0.02 -0.02 0.03
Common shares outstanding 129 128 128 127 128 129 133 131 131 131 136 136 135 137 139 134 134 114 114 131 127 123 128 128 123
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Operating cash flow + 0.00 0.03 0.01 -0.01 0.00 0.02 -0.01
Cash flow from investing + 0.01 -0.08 -0.09 -0.06 -0.02 0.00 0.00
Cash flow from financing + -0.01 -0.02 -0.04 0.01 0.21 0.12 0.00
Change in cash -0.01 -0.07 -0.13 -0.06 0.20 0.14 -0.01
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Operating cash flow + 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.01 -0.01 -0.01 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00
Cash flow from investing + -0.03 0.00 0.02 -0.02 0.01 -0.06 -0.02 0.00 -0.01 0.03 0.04 0.00 -0.17 -0.05 0.00 0.00 0.00 -0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.00 0.00 0.00 0.00 -0.01 0.00 -0.01 0.00 0.00 -0.03 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.22 0.00 0.00 0.12 0.00 0.00 0.00
Change in cash -0.03 0.00 0.02 -0.02 0.00 -0.07 -0.01 0.01 0.00 0.00 0.03 0.00 -0.17 -0.04 -0.01 -0.01 0.00 -0.01 0.22 -0.01 0.00 0.13 0.00 0.00 0.00
5 days ago

Cytek Biosciences, Inc. (CTKB) - Shares Outstanding Diluted

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Dividend Payout

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Net Income

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Stock Based Compensation

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Cashflow From Financing

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Cashflow From Investment

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Change In Inventory

1Y 2Y 5Y Max
9 days ago

Cytek Biosciences, Inc. (CTKB) - Capital Expenditures

1Y 2Y 5Y Max
9 days ago